Not me.  I think we're 2+ years and a successful phase 2(b) cancer trial away from $1Billion+ valuation. I'm being conservative here since Don can't get a decent market valuation for RVX.

12-18 months to results that the market can take seriously and 1 year to either an IPO or an acquisition from a trial partner.  I'll guess end of 2022 or first half of 2023 before we can get paid.

Should all 3 of Zenith's Phase 2 trials show positive results then I'll double my valuation guess to $2+ Billion.

I think you need patience and a bit of good luck to see a $Billion valuation in the next 2+ years.  If anything, Covid is going to slow these trials down and delay results.

good luck